Healing
TB-500 (Ac-LKKTETQ)
Longevity
7
Amino acids
Molecular weight
Peptide
Type
TB-500 (Ac-LKKTETQ) is a synthetic derivative of thymosin beta-4 consisting of the N-terminal acetylated 17-23 amino acid fragment. This sequence represents the active site within thymosin beta-4 responsible for actin binding, cell migration, and wound healing. Research shows it promotes endothelial cell differentiation, angiogenesis, keratinocyte migration, collagen deposition, and decreases inflammation. The acetylation protects against N-terminal degradation while maintaining biological activity.
TB-500 contains the LKKTETQ sequence which is the actin-binding motif of full-length thymosin beta-4. This fragment shares many properties of the parent protein regarding cell proliferation, differentiation, and migration. It promotes angiogenesis by upregulating VEGF expression and enhancing endothelial cell sprouting. The peptide undergoes serial cleavage at the C-terminus during metabolism, while the N-terminal acetylation provides protection from degradation.
Reconstituted: 2-8°C refrigerated
2x weekly (e.g., Monday and Thursday)
2-2.5mg per injection
4-6 weeks loading phase
Promotes wound healing
Enhances cell migration
Supports angiogenesis (new blood vessel formation)
Reduces inflammation
Promotes keratinocyte migration
Supports collagen deposition
Enhances tissue repair
Active region of thymosin beta-4
This peptide is still gaining traction in the community.
Thymosin Beta-4 Active Fragment | Healing Peptide
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of TB-500 (Ac-LKKTETQ).
7
Amino Acids
TB-500 (Ac-LKKTETQ)
Leu
Leu
Position 1
Lys
Lys
Position 2
Lys
Lys
Position 3
Thr
Thr
Position 4
Glu
Glu
Position 5
Thr
Thr
Position 6
Gln
Gln
Position 7
TB-500 is typically administered via subcutaneous injection. The N-terminal acetylation provides stability and protection from degradation. Not authorized for medicinal use; research peptide only.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Loading phase | 2 | 2 week range | SubQ |
| Maintenance | 2 | — | SubQ |
Materials needed:
Steps to reconstitute
The TB-500 (Ac-LKKTETQ) Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Based on your vial and dilution inputs.
Safe concentration range
TB-500 (Ac-LKKTETQ)
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg TB-500 (Ac-LKKTETQ) vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Note: Triple agonist; microdose for fewer side effects
Research suggestions of TB-500 (Ac-LKKTETQ) interactions with other common peptides and substances.
Healing
bpc
Longevity
SYNERGISTIC
Commonly combined for enhanced healing effects through different mechanisms.
Healing
ghk
Longevity
SYNERGISTIC
Both support wound healing and tissue repair through different pathways.
Growth
igf
Healing
COMPATIBLE
Different mechanisms; may complement for tissue growth.
Healing
thymos
Longevity
COMPATIBLE
TB-500 is the active fragment; combining may be redundant.
Not authorized for medicinal use
Active cancer (theoretical concern)
Pregnancy or breastfeeding
Prohibited by WADA in sports
Allergic reactions
Unusual swelling or inflammation
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
TB-500 (Ac-LKKTETQ) is a moderate research compound
TB-500 (Ac-LKKTETQ)
TB-500 (Ac-LKKTETQ) is a moderate research compound
Synthesis and Characterization of N-terminal Acetylated 17-23 Fragment of Thymosin Beta-4
TB-500 contains Ac-LKKTETQ, the active site responsible for actin binding and wound healing.
n.d.
Doping Control Analysis of TB-500
TB-500 is a synthetic version of the active region of thymosin beta-4.
n.d.
TB-500 Metabolism and Wound Healing
TB-500 undergoes serial cleavage at C-terminus; acetylation protects N-terminus.
n.d.
Investigation of TB-500 Metabolism
Characterized human metabolism of TB-500 using liver microsomes and S9 fraction.
n.d.